Patient and Clinician Perspectives on Hyperkalemia Management Under Cardio-Kidney-Protective Therapy: A Three-Stakeholder Cross-Sectional Survey
{{output}}
Background: Maintaining renin-angiotensin system inhibitor (RASi) and mineralocorticoid receptor antagonist (MRA) therapy in patients with hyperkalemia is now favored by contemporary guidelines, yet the perspectives of patients a... ...
